Viewing Study NCT04713059


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-01-01 @ 11:45 PM
Study NCT ID: NCT04713059
Status: UNKNOWN
Last Update Posted: 2021-07-01
First Post: 2021-01-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)
Sponsor: The Affiliated Hospital of Qingdao University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module